Angeles Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Angeles Wealth Management's PFE Position: Q2 2026 in Review
Angeles Wealth Management increased its Pfizer (PFE) stake by 2.2% in Q2 2026, buying an estimated $9.37K and bringing the position to 17,009 shares worth $410K. The position accounts for 0.02% of the portfolio, ranked #318.
Angeles Wealth Management first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $787K in Q4 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Angeles Wealth Management held 17,009 shares of Pfizer worth $410K as of Q2 2026.
- Angeles Wealth Management bought 358 Pfizer shares in Q2 2026, an estimated $9.37K.
- Pfizer made up 0.02% of Angeles Wealth Management's portfolio in Q2 2026, its #318 holding.
- Angeles Wealth Management first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
- Angeles Wealth Management's Pfizer position peaked at $787K in Q4 2022.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Angeles Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.